Go Pro

Evolus (EOLS) Short Interest Ratio & Short Volume

Evolus logo
$5.80 +0.25 (+4.50%)
As of 12:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Evolus Short Interest Overview

As of June 30, 2026, Evolus (EOLS) had a short interest of 6.02 million shares sold short, representing 9.62% of the public float. This marks a 2.09% increase in short interest since the prior report. The short interest ratio (days to cover) is 7.3, meaning it would take 7.3 days of the average trading volume of 1.04 million shares to cover all short positions.

Current Short Interest
6,018,141 shares
Previous Short Interest
5,895,218 shares
Change Vs. Previous Month
2.09%
Dollar Volume Sold Short
$41.77 million
Short Interest Ratio
7.3 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
65,860,000 shares
Short Percent of Float
9.62%
Today's Trading Volume
229,399 shares
Average Trading Volume
1,042,976 shares
Today's Volume Vs. Average
22%
Short Selling Evolus?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Evolus and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

EOLS Short Interest Over Time

EOLS Days to Cover Over Time

EOLS Percentage of Float Shorted Over Time

Evolus Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20266,018,141 shares $41.77 million +2.1%9.6%7.3 $6.94
6/15/20265,895,218 shares $39.79 million -2.7%9.4%8.04 $6.75
5/29/20266,059,626 shares $39.75 million -1.8%9.7%8.18 $6.56
5/15/20266,173,524 shares $40.13 million -7.3%9.9%5.33 $6.50
4/30/20266,656,973 shares $35.88 million +0.6%10.6%8.86 $5.39
4/15/20266,617,258 shares $30.64 million +1.5%10.6%9.62 $4.63
3/31/20266,517,006 shares $26.78 million -14.4%10.6%6.57 $4.11
3/13/20267,616,722 shares $38.16 million -2.5%12.5%3.21 $5.01
2/27/20267,807,678 shares $33.57 million +0.1%12.8%16.48 $4.30
2/13/20267,800,641 shares $33.54 million +5.6%12.5%8.4 $4.30
1/30/20267,389,047 shares $34.65 million +7.6%12.1%5.73 $4.69
1/15/20266,867,536 shares $34.34 million +1.2%11.3%4 $5.00
12/31/20256,785,638 shares $45.12 million +6.9%11.1%8.4 $6.65
12/15/20256,346,498 shares $45.31 million -6.3%10.4%6.92 $7.14
11/28/20256,770,213 shares $48.38 million -40.0%11.1%5.71 $7.15
11/14/202511,279,632 shares $81.44 million -14.9%18.5%4.48 $7.22
10/31/202513,255,815 shares $85.63 million +0.1%21.8%13.62 $6.46
10/15/202513,250,000 shares $87.58 million +4.5%26.1%9.7 $6.61
9/30/202512,680,000 shares $77.86 million +8.8%24.9%9.3 $6.14
9/15/202511,660,000 shares $77.31 million +0.3%22.9%8.7 $6.63
8/31/202511,630,000 shares $88.74 million +8.9%22.9%8.6 $7.63
8/15/202510,680,000 shares $71.88 million -20.8%21.1%7.5 $6.73
7/31/202513,480,000 shares $120.24 million +6.7%22.1%9.6 $8.92
7/15/202512,630,000 shares $117.08 million +5.3%N/A12.5 $9.27
6/30/202512,000,000 shares $110.52 million +13.1%19.8%11.3 $9.21
6/15/202510,610,000 shares $105.36 million +9.7%17.5%10.1 $9.93
5/31/20259,670,000 shares $90.61 million +4.7%16.3%9.7 $9.37
5/15/20259,240,000 shares $92.40 million +5.7%15.5%10.3 $10.00
4/30/20258,740,000 shares $99.64 million +14.0%N/A10 $11.40
4/15/20257,670,000 shares $78.46 million +7.3%12.9%9.1 $10.23
3/31/20257,150,000 shares $86.01 million +1.4%12.0%8.5 $12.03
3/15/20257,050,000 shares $93.06 million +3.5%11.9%9 $13.20
2/28/20256,810,000 shares $99.36 million +3.8%11.5%9 $14.59
2/15/20256,560,000 shares $96.69 million +9.5%11.0%9.1 $14.74
1/31/20255,990,000 shares $83.68 million +1.0%N/A8 $13.97
1/15/20255,930,000 shares $59.72 million +9.8%N/A8.8 $10.07
12/31/20245,400,000 shares $59.62 million +4.3%N/A8.6 $11.04
12/15/20245,180,000 shares $59.62 million -0.6%N/A8.6 $11.51
11/30/20245,210,000 shares $71.32 million -1.5%N/A8.2 $13.69
11/15/20245,290,000 shares $64.06 million -2.6%N/A8.4 $12.11
CODE RED: AI Meltdown Imminent? (Ad)

After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel

See the five simple steps to prepare before it's too late
10/31/20245,430,000 shares $88.62 million +8.8%N/A8.9 $16.32
10/15/20244,990,000 shares $83.33 million +3.1%N/A8.5 $16.70
9/30/20244,840,000 shares $78.41 million -0.8%N/A8.8 $16.20
9/15/20244,880,000 shares $85.35 million +2.3%N/A9 $17.49
8/31/20244,770,000 shares $75.80 million -1.0%N/A9.5 $15.89
8/15/20244,820,000 shares $65.55 million -4.4%N/A9.6 $13.60
7/31/20245,040,000 shares $62.60 million -4.0%N/A9.8 $12.42
7/15/20245,250,000 shares $63.37 million +10.5%9.7%9.8 $12.07
6/30/20244,750,000 shares $51.54 million +4.6%8.8%8.7 $10.85
6/15/20244,540,000 shares $51.44 million +2.0%8.4%8.3 $11.33
5/31/20244,450,000 shares $57.54 million -4.1%8.3%7.7 $12.93
5/15/20244,640,000 shares $61.43 million -2.9%8.6%7.4 $13.24
4/30/20244,780,000 shares $56.26 million +3.0%9.7%7.7 $11.77
4/15/20244,640,000 shares $55.17 million -0.2%9.6%8.1 $11.89
3/31/20244,650,000 shares $65.10 million -6.6%9.8%7.1 $14.00
3/15/20244,980,000 shares $69.22 million +0.4%10.5%7.7 $13.90
2/29/20244,960,000 shares $73.56 million +1.2%11.3%8.2 $14.83
2/15/20244,900,000 shares $67.47 million +2.9%11.1%8.1 $13.77
1/31/20244,760,000 shares $60.40 million +17.2%10.8%6.6 $12.69
1/15/20244,060,000 shares $42.83 million -7.3%9.2%5.4 $10.55
12/31/20234,380,000 shares $46.12 million -1.1%9.9%6.3 $10.53
12/15/20234,430,000 shares $43.86 million -9.0%10.0%6.5 $9.90
11/30/20234,870,000 shares $46.12 million -25.4%11.0%7.3 $9.47
11/15/20236,530,000 shares $58.18 million +60.8%14.8%10.2 $8.91
10/31/20234,060,000 shares $30.86 million +4.4%9.2%7.1 $7.60
10/15/20233,890,000 shares $31.66 million +1.3%8.8%6.5 $8.14
9/30/20233,840,000 shares $35.10 million +7.9%9.1%7.1 $9.14
9/15/20233,560,000 shares $33.61 million +5.3%8.4%6.2 $9.44
8/31/20233,380,000 shares $33.43 million -0.6%8.0%5.1 $9.89
8/15/20233,400,000 shares $34.68 million -21.7%8.1%5 $10.20
7/31/20234,340,000 shares $43.49 million -1.6%10.1%6.2 $10.02
7/15/20234,410,000 shares $32.63 million +24.6%10.3%7.8 $7.40
6/30/20233,540,000 shares $25.74 million +17.6%8.3%6.1 $7.27
6/15/20233,010,000 shares $23.15 million +7.1%7.1%5.6 $7.69
5/31/20232,810,000 shares $25.43 million -0.4%6.6%5.6 $9.05
5/15/20232,820,000 shares $29.10 million +2.2%6.6%6.4 $10.32
4/30/20232,760,000 shares $24.12 million +9.5%6.6%5.4 $8.74
4/15/20232,520,000 shares $21.14 million +4.1%6.0%4.8 $8.39
3/31/20232,420,000 shares $20.47 million +10.5%5.8%4.6 $8.46
3/15/20232,190,000 shares $18.75 million -0.9%5.2%4.1 $8.56
2/28/20232,210,000 shares $20.04 million -6.4%5.4%4.2 $9.07
2/15/20232,360,000 shares $22.11 million +6.3%5.8%4.5 $9.37
1/31/20232,220,000 shares $23.07 million -14.3%6.1%4.6 $10.39
1/15/20232,590,000 shares $22.40 million +0.4%7.0%6.2 $8.65
12/30/20222,580,000 shares $19.38 million +33.7%7.0%6.7 $7.51
12/15/20221,930,000 shares $13.55 million -15.4%5.2%4.8 $7.02
11/30/20222,280,000 shares $16.51 million -2.6%6.2%5.7 $7.24
11/15/20222,340,000 shares $17.64 million -8.2%6.3%5.7 $7.54
10/31/20222,550,000 shares $21.83 million -5.2%6.9%5.7 $8.56
10/15/20222,690,000 shares $22.41 million +24.0%7.3%5.2 $8.33
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
9/30/20222,170,000 shares $17.47 million +11.3%5.9%4.1 $8.05
9/15/20221,950,000 shares $19.81 million -5.3%5.3%3.9 $10.16
8/31/20222,060,000 shares $19.80 million -3.7%5.7%3.9 $9.61
8/15/20222,140,000 shares $20.24 million +6.5%6.0%4 $9.46
7/31/20222,010,000 shares $24.78 million -7.4%5.6%3.4 $12.33
7/15/20222,170,000 shares $27.80 million -8.1%6.1%4.3 $12.81
6/30/20222,360,000 shares $27.38 million -8.2%6.6%4.7 $11.60
6/15/20222,570,000 shares $30.40 million -13.2%7.2%5.1 $11.83
5/31/20222,960,000 shares $38.18 million -2.6%8.3%5.8 $12.90
5/15/20223,040,000 shares $40.07 million +22.1%8.5%6.2 $13.18
4/30/20222,490,000 shares $27.86 million +9.2%7.0%5.5 $11.19
4/15/20222,280,000 shares $25.72 million -1.7%6.4%4.7 $11.28
3/31/20222,320,000 shares $26.03 million -7.2%6.6%4.7 $11.22
3/15/20222,500,000 shares $24.88 million +4.2%7.1%5 $9.95
2/28/20222,400,000 shares $21.96 million -4.4%6.8%5 $9.15
2/15/20222,510,000 shares $22.82 million -12.5%7.1%5.1 $9.09
1/31/20222,870,000 shares $21.30 million +6.7%8.2%5.9 $7.42
1/15/20222,690,000 shares $15.47 million +3.5%N/A0 $5.75
12/31/20212,600,000 shares $16.93 million +12.1%7.2%6 $6.51
12/15/20212,320,000 shares $13.48 million +7.9%6.4%4.8 $5.81
11/30/20212,150,000 shares $11.91 million +1.9%6.0%4.3 $5.54
11/15/20212,110,000 shares $14.98 million -4.5%5.9%4.1 $7.10
10/29/20212,210,000 shares $17.28 million -11.6%6.1%4.2 $7.82
10/15/20212,500,000 shares $19.18 million +4.6%7.1%4.7 $7.67
9/30/20212,390,000 shares $18.21 million -1.2%6.8%4.6 $7.62
9/15/20212,420,000 shares $19.60 million -3.6%6.8%4.6 $8.10
8/31/20212,510,000 shares $26.61 million -21.6%7.7%4.7 $10.60
8/13/20213,200,000 shares $33.92 million -10.4%9.7%6.3 $10.60
7/30/20213,570,000 shares $38.63 million +1.7%10.7%6.4 $10.82

EOLS Short Interest - Frequently Asked Questions

Short interest is the volume of Evolus shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 6,018,141 shares of EOLS short. 9.62% of Evolus' shares are currently sold short. Learn More on Evolus' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EOLS shares currently have a short interest ratio of 7.3. Learn More on Evolus's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.62% of Evolus' floating shares are currently sold short.

Evolus saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 6,018,141 shares, an increase of 2.1% from the previous total of 5,895,218 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

9.62% of Evolus' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evolus: Maze Therapeutics, Inc. (10.55%), Vir Biotechnology, Inc. (11.72%), Maplight Therapeutics, Inc. (6.29%), Immunocore Holdings PLC Sponsored ADR (19.66%), Septerna, Inc. (7.43%), Harrow, Inc. (21.99%), Maravai LifeSciences Holdings, Inc. (3.50%), ArriVent BioPharma, Inc. (17.91%), MoonLake Immunotherapeutics (10.13%), Aktis Oncology (6.40%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling EOLS is an investing strategy that aims to generate trading profit from Evolus as its price is falling. EOLS shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Evolus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EOLS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EOLS, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like EOLS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:EOLS) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners